# Is There an Interest in Repeating the Vaginal Administration of Dinoprostone (Propess®), to Promote Induction of Labor of Pregnant Women at Term?

> **NCT02888041** · PHASE3 · TERMINATED · sponsor: **University Hospital, Limoges** · enrollment: 160 (actual)

## Conditions studied

- Cervical Ripening
- Pregnancy

## Interventions

- **DRUG:** Dinoprostone
- **DRUG:** Oxytocine

## Key facts

- **NCT ID:** NCT02888041
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12
- **Primary completion:** 2022-04-23
- **Final completion:** 2022-04-23
- **Target enrollment:** 160 (ACTUAL)
- **Why stopped:** Not enough patients
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888041, "Is There an Interest in Repeating the Vaginal Administration of Dinoprostone (Propess®), to Promote Induction of Labor of Pregnant Women at Term?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02888041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*